Treatment News : Blood Protein in the Kidneys Predict a Higher Death Risk in HIV-Positive Women

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » September 2010

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

September 8, 2010

Blood Protein in the Kidneys Predict a Higher Death Risk in HIV-Positive Women

Microalbuminuria—where low levels of a protein called albumin leak from the kidneys into urine—is associated with a much higher risk of death in HIV-positive women, according to a study published in the September 1 issue of the Journal of Acquired Immune Deficiency Syndromes. Proteinuria—the presence of any protein in urine—was also associated with increased mortality among women living with HIV in the study.

The kidneys are critical to filtering out toxins from the blood stream, while leaving in place blood proteins and other things that the body needs to remain healthy. Occasionally, when the filters in the kidneys become damaged, blood proteins can filter into the urine. Diabetes and high blood pressure are the most common culprits of kidney disease. People with a number of chronic diseases, including HIV and hepatitis, regularly have their urine tested for the presence of blood proteins. When proteins of any kind are present, this condition is called “proteinuria.”

Albumin is a specific blood protein that can leak into urine. When it does, it is often a sign of either cardiovascular disease or kidney disease. Microalbuminuria has been strongly associated with an increase in premature death in the general public. Though higher rates of the condition have been noted in people with HIV, researchers have never explored whether these higher rates are associated with an increased risk of death.

To examine this question, Christina Wyatt, MD, from the Mount Sinai School of Medicine in New York City, and her colleagues studied the results of two urine tests in 1,547 HIV-positive women enrolled in the Women’s Interagency HIV Study (WIHS). Women were included if they had at least two eligible urine samples at least six months apart.

The women were tested for both proteinuria and microalbuminuria. Participants were classified as having “confirmed” microalbuminuria if they had either microalbuminuria at two study visits, or microalbuminuria at one visit and proteinuria at the other study visit. They were considered to have “unconfirmed” microalbuminuria if they had microalbuminuria at only one study visit, and they were considered to not have microalbuminuria if albumin could not be found in the urine at either study visit.

Of the more than 1,500 women, 1,261 had no microalbuminuria, 165 had unconfirmed microalbuminuria, 64 had confirmed microalbuminuria, and 57 had proteinuria. The demographics differed depending on the presence of protein in the kidneys. Women with no microalbuminuria were younger than the women in the other groups, more likely to be white, and less likely to have diabetes, high blood pressure or hepatitis B virus infection.

Wyatt and her colleagues found that the presence of protein in the urine was highly predictive of mortality. Women with unconfirmed microalbuminuria were 3.4 times as likely to die prematurely as women with no microalbuminuria. Women with confirmed microalbuminuria were 3.9 times as likely to die, and women with proteinuria had a death rate that was 5.9 times higher.

Though these numbers dropped when Wyatt’s team accounted for factors such as race, CD4 count and previous AIDS-related illnesses, the increased death rate was still at least twice as high in women with protein in their urine. Systolic blood pressure was highly associated with microalbuminuria, but no other factors were, including whether or not a person was taking antiretroviral (ARV) therapy.

The authors acknowledge that their study only included women, most of whom were enrolled before the modern combination ARV era. Moreover, because most of the deaths were AIDS-related, it was difficult to tease out the individual contribution of microalbuminuria and also difficult to pinpoint the cause of this condition. Nevertheless, the authors concluded that testing for microalbuminuria could help predict which people with HIV are at increased risk for dying early and may be a good early warning sign of cardiovascular disease.

“Future studies should investigate whether microalbuminuria is associated with mortality in other HIV-infected populations and whether microalbuminuria testing is a cost-effective approach to identify patients who may benefit from earlier intervention,” the authors concluded.

Search: Microalbuminuria, albumin, proteinuria, kidney, urine, diabetes, high blood pressure, Christina Wyatt, mortality


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    chipper52
    Palm Springs
    California


    newlife202
    JOLIET
    Illinois


    youngbloodlatino
    Columbia
    Maryland


    josebos
    Boston strong
    Massachusetts
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.